| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | lyase activity | ACO1 ADCY1 ADCY3 FASN GLDC L3HYPDH PISD ALOX12B ILVBL CHAC1 HADHB HDC | 2.66e-06 | 212 | 210 | 12 | GO:0016829 |
| GeneOntologyMolecularFunction | dihydropyrimidinase activity | 2.24e-05 | 6 | 210 | 3 | GO:0004157 | |
| GeneOntologyMolecularFunction | kinase activity | SMG1 EPHA6 TRPM7 MAP3K12 PGK1 PGK2 PTK2 MYO3A PIK3C2G UCKL1 MYO3B MERTK PLK3 WNK4 ELP1 ACVR1C PIP5K1C TGFBR1 DCLK3 MAST1 SBK2 | 5.93e-05 | 764 | 210 | 21 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 1.10e-04 | 2 | 210 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SMG1 EPHA6 TRPM7 MAP3K12 PTK2 MYO3A PIK3C2G UCKL1 MYO3B MERTK PLK3 WNK4 ELP1 ACVR1C PIP5K1C TGFBR1 DCLK3 MAST1 SBK2 | 1.87e-04 | 709 | 210 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 3.28e-04 | 3 | 210 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 3.28e-04 | 3 | 210 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SMG1 EPHA6 TRPM7 MAP3K12 PGK1 PGK2 PTK2 MYO3A PIK3C2G UCKL1 MYO3B MERTK PLK3 WNK4 DNTT ELP1 ACVR1C PIP5K1C TGFBR1 DCLK3 MAST1 SBK2 | 3.77e-04 | 938 | 210 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 5.80e-04 | 16 | 210 | 3 | GO:0016812 | |
| GeneOntologyMolecularFunction | protein kinase activity | SMG1 EPHA6 TRPM7 MAP3K12 PTK2 MYO3A MYO3B MERTK PLK3 WNK4 ELP1 ACVR1C TGFBR1 DCLK3 MAST1 SBK2 | 6.37e-04 | 600 | 210 | 16 | GO:0004672 |
| GeneOntologyBiologicalProcess | microtubule-based process | STAG1 TUBA8 NPHP4 DDB1 ADCY3 PGK2 PTK2 DST VPS13A WDR35 BSN PPP2R3C PLK3 CNTN2 LCA5 RAB17 ANK3 IFT74 DYNC2I1 TTLL7 RGS14 RASGRP1 LRPPRC C2CD3 NPHP3 LLGL2 LLGL1 CDK5RAP2 CKAP2 HTT | 3.31e-07 | 1058 | 209 | 30 | GO:0007017 |
| GeneOntologyBiologicalProcess | transport along microtubule | DST WDR35 BSN LCA5 RAB17 ANK3 IFT74 DYNC2I1 RASGRP1 LRPPRC HTT | 5.62e-06 | 197 | 209 | 11 | GO:0010970 |
| GeneOntologyBiologicalProcess | microtubule-based transport | DST WDR35 BSN LCA5 RAB17 ANK3 IFT74 DYNC2I1 RASGRP1 LRPPRC NPHP3 HTT | 1.11e-05 | 253 | 209 | 12 | GO:0099111 |
| GeneOntologyBiologicalProcess | intracellular transport | SMG1 MPDZ ARFIP2 PTK2 DST VPS35L VPS13A WDR35 TMED10 BSN HEATR5B PLK3 HSP90AA1 KPNA3 KPNA4 LCA5 RAB17 ANK3 GOPC IFT74 NUP43 DYNC2I1 HPS3 PPM1A RGS14 RASGRP1 LRPPRC NUS1 LRP1 MTX1 VPS13B HTT UEVLD | 1.90e-05 | 1496 | 209 | 33 | GO:0046907 |
| GeneOntologyBiologicalProcess | lipid localization | ACACB ATG2A SLC10A7 ABCA7 ABCA8 ESYT2 VPS13A C3 PISD WNK4 ATG2B RNF213 PPARA ACVR1C NUS1 PITPNM3 LRP1 VPS13B | 1.93e-05 | 565 | 209 | 18 | GO:0010876 |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | DST WDR35 BSN LCA5 RAB17 ANK3 IFT74 DYNC2I1 RASGRP1 LRPPRC HTT | 1.96e-05 | 225 | 209 | 11 | GO:0030705 |
| GeneOntologyBiologicalProcess | axonogenesis | CHL1 EPHA6 DPYSL5 ADCY1 PTK2 SLITRK2 DST PTPRS CNTN2 ANK3 APLP1 PIP5K1C PLEKHG4B LLGL1 UNC5C LRP1 CDH2 RPL4 | 1.98e-05 | 566 | 209 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CHL1 EPHA6 DPYSL5 ADCY1 PTK2 MYO3A SLITRK2 DST PTPRS MYO3B CNTN2 ANK3 FAT3 APLP1 PIP5K1C PLEKHG4B LLGL1 UNC5C LRP1 CDH2 RPL4 | 2.56e-05 | 748 | 209 | 21 | GO:0048667 |
| GeneOntologyBiologicalProcess | microtubule-based movement | NPHP4 ADCY3 PGK2 DST VPS13A WDR35 BSN LCA5 RAB17 ANK3 IFT74 DYNC2I1 RASGRP1 LRPPRC NPHP3 HTT | 4.56e-05 | 493 | 209 | 16 | GO:0007018 |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 5.53e-05 | 8 | 209 | 3 | GO:2000427 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase catabolic process | 5.53e-05 | 8 | 209 | 3 | GO:0006208 | |
| GeneOntologyBiologicalProcess | neuron development | CHL1 EPHA6 DPYSL5 MPDZ NPHP4 ADCY1 PTK2 MYO3A SLITRK2 DST PTPRS MYO3B VPS13A C3 CNTN2 DPYSL2 RAB17 ANK3 FAT3 CRTC1 APLP1 PIP5K1C LHX6 PLEKHG4B LLGL1 UNC5C LRP1 CDH2 RPL4 VPS13B HTT | 7.44e-05 | 1463 | 209 | 31 | GO:0048666 |
| GeneOntologyBiologicalProcess | axon development | CHL1 EPHA6 DPYSL5 ADCY1 PTK2 SLITRK2 DST PTPRS CNTN2 ANK3 APLP1 PIP5K1C PLEKHG4B LLGL1 UNC5C LRP1 CDH2 RPL4 | 1.01e-04 | 642 | 209 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 1.10e-04 | 25 | 209 | 4 | GO:0051481 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 1.17e-04 | 10 | 209 | 3 | GO:2000425 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 1.22e-04 | 48 | 209 | 5 | GO:0043277 | |
| GeneOntologyCellularComponent | dendrite | CHL1 EPHA6 DPYSL5 MPDZ PTK2 SLITRK2 BSN FUBP3 PLK3 HSP90AA1 DPYSL2 RAB17 ANK3 GOPC FAT3 CRTC1 GRM5 TRIM3 TTLL7 RGS14 SLC8A1 UNC5C LRP1 MAST1 HTT HDC | 4.51e-07 | 858 | 208 | 26 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CHL1 EPHA6 DPYSL5 MPDZ PTK2 SLITRK2 BSN FUBP3 PLK3 HSP90AA1 DPYSL2 RAB17 ANK3 GOPC FAT3 CRTC1 GRM5 TRIM3 TTLL7 RGS14 SLC8A1 UNC5C LRP1 MAST1 HTT HDC | 4.71e-07 | 860 | 208 | 26 | GO:0097447 |
| GeneOntologyCellularComponent | postsynaptic density | MPDZ ADCY1 DST PTPRS BSN DPYSL2 ANK3 GOPC CRTC1 GRM5 PIP5K1C RGS14 SLC8A1 DROSHA LRP1 CDH2 RPL4 | 2.96e-06 | 451 | 208 | 17 | GO:0014069 |
| GeneOntologyCellularComponent | postsynaptic specialization | MPDZ ADCY1 DST PTPRS BSN DPYSL2 RAPSN ANK3 GOPC CRTC1 GRM5 PIP5K1C RGS14 SLC8A1 DROSHA LRP1 CDH2 RPL4 | 3.11e-06 | 503 | 208 | 18 | GO:0099572 |
| GeneOntologyCellularComponent | somatodendritic compartment | CHL1 EPHA6 TRPM7 DPYSL5 MPDZ PTK2 SLITRK2 PTPRS VPS13A BSN FUBP3 PLK3 CNTN2 HSP90AA1 DPYSL2 RAB17 ANK3 GOPC FAT3 CRTC1 GRM5 TRIM3 TTLL7 RGS14 SLC8A1 UNC5C LRP1 MAST1 HTT HDC | 4.81e-06 | 1228 | 208 | 30 | GO:0036477 |
| GeneOntologyCellularComponent | asymmetric synapse | MPDZ ADCY1 DST PTPRS BSN DPYSL2 ANK3 GOPC CRTC1 GRM5 PIP5K1C RGS14 SLC8A1 DROSHA LRP1 CDH2 RPL4 | 6.23e-06 | 477 | 208 | 17 | GO:0032279 |
| GeneOntologyCellularComponent | cell-cell junction | MPDZ KEAP1 NPHP4 PTK2 DST MPP4 AHNAK DNMBP WNK4 NPHS1 ANK3 PIP5K1C PLEKHG4B TGFBR1 SLC8A1 LLGL2 LLGL1 CDH2 CDH13 | 7.68e-06 | 591 | 208 | 19 | GO:0005911 |
| GeneOntologyCellularComponent | neuron to neuron synapse | MPDZ ADCY1 DST PTPRS BSN DPYSL2 ANK3 GOPC CRTC1 GRM5 PIP5K1C RGS14 SLC8A1 DROSHA LRP1 CDH2 RPL4 | 2.05e-05 | 523 | 208 | 17 | GO:0098984 |
| GeneOntologyCellularComponent | basal part of cell | SLC29A2 ABCA8 PTK2 DST MPP4 HSP90AA1 RAB17 ANK3 PLEKHG4B TGFBR1 SLC8A1 LLGL1 LRP1 CDH2 | 2.75e-05 | 378 | 208 | 14 | GO:0045178 |
| GeneOntologyCellularComponent | postsynapse | MPDZ ADCY1 PTK2 ADRA1A SLITRK2 DST PTPRS BSN CNTN2 DPYSL2 RAPSN RAB17 ANK3 GOPC CRTC1 GRM5 PIP5K1C TRIM3 RGS14 SLC8A1 DROSHA LRP1 CDH2 RPL4 HTT | 2.94e-05 | 1018 | 208 | 25 | GO:0098794 |
| GeneOntologyCellularComponent | basal plasma membrane | SLC29A2 ABCA8 PTK2 DST HSP90AA1 RAB17 ANK3 PLEKHG4B TGFBR1 SLC8A1 LLGL1 LRP1 CDH2 | 5.83e-05 | 354 | 208 | 13 | GO:0009925 |
| GeneOntologyCellularComponent | fatty acid beta-oxidation multienzyme complex | 2.94e-04 | 3 | 208 | 2 | GO:0036125 | |
| GeneOntologyCellularComponent | mitochondrial fatty acid beta-oxidation multienzyme complex | 2.94e-04 | 3 | 208 | 2 | GO:0016507 | |
| GeneOntologyCellularComponent | phagophore | 2.94e-04 | 3 | 208 | 2 | GO:0061908 | |
| GeneOntologyCellularComponent | anchoring junction | MPDZ KEAP1 NPHP4 PTK2 DOCK5 DST MPP4 AHNAK DNMBP WNK4 NPHS1 ANK3 PIP5K1C PLEKHG4B TGFBR1 SLC8A1 LLGL2 LLGL1 LRP1 CDH2 RPL4 CDH13 | 3.05e-04 | 976 | 208 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell contact zone | 3.55e-04 | 94 | 208 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC29A2 ABCA8 PTK2 HSP90AA1 RAB17 ANK3 TGFBR1 SLC8A1 LLGL1 LRP1 CDH2 | 3.80e-04 | 320 | 208 | 11 | GO:0016323 |
| GeneOntologyCellularComponent | cell body | TRPM7 DPYSL5 PTPRS VPS13A BSN FUBP3 PLK3 WNK4 CNTN2 HSP90AA1 DPYSL2 RAB17 CRTC1 TTLL7 SLC8A1 UNC5C PITPNM3 LRP1 MAST1 HTT HDC | 4.04e-04 | 929 | 208 | 21 | GO:0044297 |
| GeneOntologyCellularComponent | intercalated disc | 5.83e-04 | 68 | 208 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | sarcolemma | 6.50e-04 | 190 | 208 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | neuronal cell body | TRPM7 DPYSL5 PTPRS VPS13A BSN FUBP3 PLK3 CNTN2 HSP90AA1 DPYSL2 RAB17 CRTC1 TTLL7 SLC8A1 UNC5C LRP1 MAST1 HTT HDC | 7.08e-04 | 835 | 208 | 19 | GO:0043025 |
| GeneOntologyCellularComponent | synaptic membrane | ADCY1 ADRA1A SLITRK2 MPP4 PTPRS BSN CNTN2 RAPSN ANK3 GRM5 PIP5K1C SLC8A1 LRP1 CDH2 HTT | 7.72e-04 | 583 | 208 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | microtubule organizing center | KEAP1 NPHP4 PTK2 WDR35 PPP2R3C PLK3 LCA5 RAPSN IFT74 DYNC2I1 CCDC141 RBM39 TTLL7 RGS14 C2CD3 LRP1 CDK5RAP2 CKAP2 CABCOCO1 HTT | 8.89e-04 | 919 | 208 | 20 | GO:0005815 |
| GeneOntologyCellularComponent | lipid droplet | 1.08e-03 | 116 | 208 | 6 | GO:0005811 | |
| GeneOntologyCellularComponent | T-tubule | 1.15e-03 | 79 | 208 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | basement membrane | 1.40e-03 | 122 | 208 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | glutamatergic synapse | DPYSL5 MPDZ ADCY1 PTK2 ADRA1A SLITRK2 PTPRS BSN RAB17 CRTC1 GRM5 PIP5K1C TRIM3 RGS14 DROSHA LRP1 CDH2 HTT | 1.40e-03 | 817 | 208 | 18 | GO:0098978 |
| GeneOntologyCellularComponent | activin receptor complex | 1.44e-03 | 6 | 208 | 2 | GO:0048179 | |
| GeneOntologyCellularComponent | centrosome | KEAP1 NPHP4 PTK2 WDR35 PPP2R3C PLK3 LCA5 RAPSN IFT74 DYNC2I1 CCDC141 RBM39 RGS14 C2CD3 CDK5RAP2 CKAP2 CABCOCO1 | 1.86e-03 | 770 | 208 | 17 | GO:0005813 |
| GeneOntologyCellularComponent | postsynaptic membrane | ADCY1 ADRA1A SLITRK2 PTPRS CNTN2 RAPSN ANK3 GRM5 SLC8A1 LRP1 CDH2 | 2.54e-03 | 405 | 208 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | condensin complex | 2.65e-03 | 8 | 208 | 2 | GO:0000796 | |
| HumanPheno | Abnormal hippocampus morphology | 1.39e-05 | 48 | 87 | 7 | HP:0025100 | |
| HumanPheno | Abnormal morphology of the limbic system | 1.60e-05 | 49 | 87 | 7 | HP:0007343 | |
| HumanPheno | Phonic tics | 4.70e-05 | 5 | 87 | 3 | HP:0100035 | |
| Domain | Autophagy-rel_C | 7.85e-08 | 5 | 211 | 4 | IPR015412 | |
| Domain | ATG_C | 7.85e-08 | 5 | 211 | 4 | PF09333 | |
| Domain | Chorein_N | 1.07e-06 | 8 | 211 | 4 | PF12624 | |
| Domain | VPS13_N | 1.07e-06 | 8 | 211 | 4 | IPR026854 | |
| Domain | NHL_repeat | 3.15e-06 | 10 | 211 | 4 | IPR001258 | |
| Domain | NHL | 3.15e-06 | 10 | 211 | 4 | PF01436 | |
| Domain | - | 4.63e-06 | 39 | 211 | 6 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.24e-05 | 46 | 211 | 6 | IPR011042 | |
| Domain | Hydantoinase/dihydroPyrase | 2.77e-05 | 6 | 211 | 3 | IPR011778 | |
| Domain | ARM-type_fold | SMG1 TRPC4AP STAG1 RYR3 DOCK5 PIK3C2G HEATR5B KPNA3 KPNA4 NCAPD3 RNPEPL1 MROH1 DAAM2 HTT | 3.31e-05 | 339 | 211 | 14 | IPR016024 |
| Domain | - | 7.63e-05 | 8 | 211 | 3 | 2.30.40.10 | |
| Domain | NHL_repeat_subgr | 1.14e-04 | 9 | 211 | 3 | IPR013017 | |
| Domain | PGK | 1.27e-04 | 2 | 211 | 2 | PF00162 | |
| Domain | Phosphoglycerate_kinase_CS | 1.27e-04 | 2 | 211 | 2 | IPR015911 | |
| Domain | DUF5050 | 1.27e-04 | 2 | 211 | 2 | IPR032485 | |
| Domain | Phosphoglycerate_kinase_C | 1.27e-04 | 2 | 211 | 2 | IPR015901 | |
| Domain | PGLYCERATE_KINASE | 1.27e-04 | 2 | 211 | 2 | PS00111 | |
| Domain | Phosphoglycerate_kinase_N | 1.27e-04 | 2 | 211 | 2 | IPR015824 | |
| Domain | - | 1.27e-04 | 2 | 211 | 2 | 3.40.50.1270 | |
| Domain | - | 1.27e-04 | 2 | 211 | 2 | 3.40.50.1260 | |
| Domain | ATG2 | 1.27e-04 | 2 | 211 | 2 | IPR026849 | |
| Domain | ATG2_CAD | 1.27e-04 | 2 | 211 | 2 | PF13329 | |
| Domain | DUF5050 | 1.27e-04 | 2 | 211 | 2 | PF16472 | |
| Domain | ATG2_CAD_motif | 1.27e-04 | 2 | 211 | 2 | IPR026885 | |
| Domain | Kinase-like_dom | SMG1 EPHA6 TRPM7 MAP3K12 PTK2 MYO3A DST PIK3C2G MYO3B MERTK PLK3 WNK4 ACVR1C TGFBR1 DCLK3 MAST1 SBK2 | 1.50e-04 | 542 | 211 | 17 | IPR011009 |
| Domain | IG_FLMN | 1.61e-04 | 10 | 211 | 3 | SM00557 | |
| Domain | Amidohydro_1 | 1.61e-04 | 10 | 211 | 3 | PF01979 | |
| Domain | Metal-dep_hydrolase_composite | 1.61e-04 | 10 | 211 | 3 | IPR011059 | |
| Domain | Filamin | 2.19e-04 | 11 | 211 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.19e-04 | 11 | 211 | 3 | PS50194 | |
| Domain | Filamin/ABP280_repeat-like | 2.19e-04 | 11 | 211 | 3 | IPR017868 | |
| Domain | Amidohydro-rel | 2.19e-04 | 11 | 211 | 3 | IPR006680 | |
| Domain | Filamin/ABP280_rpt | 2.19e-04 | 11 | 211 | 3 | IPR001298 | |
| Domain | NHL | 3.74e-04 | 13 | 211 | 3 | PS51125 | |
| Domain | Peptidase_S54_rhomboid_met | 3.78e-04 | 3 | 211 | 2 | IPR017213 | |
| Domain | Phosphoglycerate_kinase | 3.78e-04 | 3 | 211 | 2 | IPR001576 | |
| Domain | Bbox_C | 5.85e-04 | 15 | 211 | 3 | IPR003649 | |
| Domain | BBC | 5.85e-04 | 15 | 211 | 3 | SM00502 | |
| Domain | Cu-oxidase_2 | 7.51e-04 | 4 | 211 | 2 | IPR011706 | |
| Domain | VPS13_C | 7.51e-04 | 4 | 211 | 2 | IPR031645 | |
| Domain | Cu-oxidase_2 | 7.51e-04 | 4 | 211 | 2 | PF07731 | |
| Domain | LLGL | 7.51e-04 | 4 | 211 | 2 | PF08366 | |
| Domain | SHR-BD | 7.51e-04 | 4 | 211 | 2 | IPR009543 | |
| Domain | Lethal2_giant | 7.51e-04 | 4 | 211 | 2 | IPR000664 | |
| Domain | VPS13_C | 7.51e-04 | 4 | 211 | 2 | PF16909 | |
| Domain | SHR-BD | 7.51e-04 | 4 | 211 | 2 | PF06650 | |
| Domain | LLGL2 | 7.51e-04 | 4 | 211 | 2 | IPR013577 | |
| Domain | HEAT_REPEAT | 1.17e-03 | 70 | 211 | 5 | PS50077 | |
| Domain | Cu-oxidase_3 | 1.24e-03 | 5 | 211 | 2 | IPR011707 | |
| Domain | Cu-oxidase_3 | 1.24e-03 | 5 | 211 | 2 | PF07732 | |
| Domain | MULTICOPPER_OXIDASE1 | 1.24e-03 | 5 | 211 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 1.24e-03 | 5 | 211 | 2 | IPR033138 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRPC4AP EPHA6 DPYSL5 SLC10A7 MAP3K12 ADCY1 ADCY3 PTK2 DOCK5 ESYT2 PTPRS UCKL1 VPS35L PISD CHD6 ANKRD12 COL5A1 DPYSL2 SLC25A42 SLC9A8 RAB17 ANK3 SEPTIN5 ABHD2 DYNC2I1 RNF213 PPARA RBM39 HPS3 PLEKHG4B LRPPRC GTF2I LRP1 MAST1 PNPLA7 CKAP2 MBD5 CATSPERG VPS13B HTT SOS2 | 4.32e-16 | 1489 | 212 | 41 | 28611215 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ACACB DPYSL5 HLCS ATG2A TUBA8 ARFIP2 LRP1B DDB1 ESYT2 HROB DNMBP HSP90AA1 LCA5 DPYSL2 IFT74 RNF135 NUP43 DYNC2I1 DPYSL4 CRTC1 RBM39 PPM1A C2CD3 CKAP2 | 5.97e-10 | 853 | 212 | 24 | 28718761 |
| Pubmed | HDAC9 STAG1 TRPM7 ACO1 HLCS TFIP11 LRP1B PGK1 PTK2 RYR3 DST VPS35L DLST CHD6 MERTK HSP90AA1 KPNA3 KPNA4 DPYSL2 ANK3 IFT74 NUP43 DYNC2I1 DROSHA LRP1 MAST1 DAAM2 CKAP2 SOS2 | 1.42e-09 | 1285 | 212 | 29 | 35914814 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ILF3 TFIP11 MCM10 DDB1 PGK1 PTK2 FASN DST AHNAK DLST FUBP3 ALOX12B HSP90AA1 PNP KPNA3 DPYSL2 ELP1 FARSB NAA50 NCAPH RBM39 LRPPRC GTF2I LLGL1 TFB1M MTHFD1 HADHB SNRPD3 RPL4 | 4.49e-09 | 1353 | 212 | 29 | 29467282 |
| Pubmed | ILF3 KDM3B PTK2 DST PIK3C2G MPP4 PTPRS GLDC UCKL1 PISD MERTK BSN HSDL1 HSP90AA1 SEPTIN5 FASTKD1 DPYSL4 NCAPH RBM39 FEM1B UNC5C PITPNM3 MAST1 PNPLA7 | 1.46e-08 | 1006 | 212 | 24 | 15226823 | |
| Pubmed | ACACB TRPM7 KDM3B MCM10 ARFIP2 PGK1 DOCK5 DST AHNAK VPS13A HSP90AA1 ANK3 GOPC RNF213 NCAPH GTF2I MTHFD1 UNC5C CDK5RAP2 RPL4 STOM | 1.51e-08 | 777 | 212 | 21 | 35844135 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ILF3 ACACB KDM3B HLCS TFIP11 KEAP1 DDB1 PGK1 FASN DST AHNAK HSP90AA1 DPYSL2 ATG2B FARSB DPYSL4 NCAPH RBM39 GTF2I MTHFD1 CKAP2 SNRPD3 RPL4 | 1.68e-08 | 934 | 212 | 23 | 33916271 |
| Pubmed | ILF3 DPYSL5 DDB1 PGK1 FASN DST PTPRS DLST BSN HSDL1 CNTN2 HSP90AA1 KPNA3 DPYSL2 ANK3 SEPTIN5 ELP1 FARSB DPYSL4 GRM5 RBM39 TRIM3 LRPPRC MTHFD1 MAST1 HADHB CDH2 RPL4 | 5.82e-08 | 1431 | 212 | 28 | 37142655 | |
| Pubmed | SMG1 ILF3 ACACB STAG1 TTC16 PABPC5 PGK1 PGK2 FASN DST AHNAK VPS13A DLST CHD6 BSN FUBP3 HSP90AA1 KPNA4 PPARA NCAPH RGS14 LRPPRC C2CD3 UNC5C MARF1 ANKRD30A HADHB RPL4 | 6.82e-08 | 1442 | 212 | 28 | 35575683 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ARFIP2 DDB1 ESYT2 FASN AHNAK DLST TMED10 ILVBL HSP90AA1 PNP DPYSL2 GOPC FASTKD1 ELP1 RNF213 ACSF2 RBM39 GFM2 LRPPRC THBS2 UNC5C LRP1 HADHB PNPLA7 CATSPERG SNRPD3 RPL4 STOM | 7.75e-08 | 1451 | 212 | 28 | 30550785 |
| Pubmed | ILF3 STAG1 DDB1 PGK1 AHNAK C3 DLST TMED10 FUBP3 HSP90AA1 NUP43 LRPPRC GTF2I HADHB CKAP2 SNRPD3 RPL4 STOM | 1.24e-07 | 652 | 212 | 18 | 31180492 | |
| Pubmed | ILF3 MPDZ KEAP1 DDB1 PGK1 PTK2 DST PTPRS TMED10 BSN HSP90AA1 DPYSL2 ANK3 SEPTIN5 FARSB DPYSL4 GRM5 TRIM3 LRPPRC LRP1 CDK5RAP2 CDH2 | 1.28e-07 | 963 | 212 | 22 | 28671696 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TRPC4AP LZTR1 DPYSL5 MPDZ NHLRC2 DDB1 ESYT2 FASN PTPRS C3 TMED10 FUBP3 NCAPD3 DPYSL2 GOPC DUSP1 ELP1 FARSB LRPPRC GTF2I LRP1 RPL4 | 1.56e-07 | 974 | 212 | 22 | 28675297 |
| Pubmed | CHL1 HDAC9 ILF3 EPHA6 DPYSL5 MYO3A MYO3B HEPHL1 FYB2 CCDC33 KPNA3 COL4A1 RAB17 ABHD2 TTLL7 THBS2 SLC8A1 UNC5C CABCOCO1 CDH2 | 1.57e-07 | 814 | 212 | 20 | 23251661 | |
| Pubmed | E2F7 DDB1 ESYT2 FASN GLDC TMED10 FUBP3 HSP90AA1 KPNA3 DPYSL2 MAT2B FARSB RBM39 LRPPRC GTF2I MTHFD1 | 2.15e-07 | 534 | 212 | 16 | 35032548 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ILF3 KEAP1 DDB1 ESYT2 FASN PISD TMED10 FUBP3 HSDL1 ILVBL HSP90AA1 PNP KPNA3 NCAPD3 DUSP1 ELP1 FARSB RBM39 PPM1A LRPPRC GTF2I MTHFD1 HADHB SNRPD3 RPL4 | 2.35e-07 | 1257 | 212 | 25 | 37317656 |
| Pubmed | ILF3 E2F7 KEAP1 DDB1 PGK1 FASN DLST FUBP3 HSP90AA1 FARSB RBM39 LRPPRC GTF2I MTHFD1 HADHB RPL4 | 3.26e-07 | 551 | 212 | 16 | 34728620 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LZTR1 KDM3B ATG2A NPHP4 SLC29A2 ABCA7 FASN DST PTPRS UCKL1 AHNAK DNMBP PPP2R3C MYRF PLK3 RNPEPL1 PPARA PIP5K1C C2CD3 LLGL2 MROH1 MBD5 HTT | 3.37e-07 | 1105 | 212 | 23 | 35748872 |
| Pubmed | ILF3 HLCS MPDZ KEAP1 DDB1 ESYT2 FASN DST AHNAK HSP90AA1 ANK3 ATG2B FARSB NAA50 LRPPRC LLGL1 MTHFD1 RPL4 | 4.12e-07 | 708 | 212 | 18 | 39231216 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ACACB KEAP1 ATG2A PTK2 DOCK5 BSN WNK4 KPNA3 KPNA4 ANK3 PIP5K1C CCDC141 PLEKHG4B SOS2 | 4.71e-07 | 430 | 212 | 14 | 35044719 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ILF3 TRPM7 DDB1 ESYT2 DST VPS13A DLST TMED10 FUBP3 HSDL1 GOPC FASTKD1 ATG2B ELP1 DYNC2I1 RNF213 NAA50 RBM39 GFM2 LRPPRC CDK5RAP2 HADHB CKAP2 MTX1 RPL4 VPS13B STOM | 5.02e-07 | 1496 | 212 | 27 | 32877691 |
| Pubmed | ILF3 ACACB DDB1 PGK1 FASN HSP90AA1 NUP43 RBM39 MTHFD1 HADHB SNRPD3 RPL4 STOM | 6.43e-07 | 377 | 212 | 13 | 25147182 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ILF3 MPDZ NHLRC2 DDB1 PGK1 FASN DST AHNAK TMED10 HSP90AA1 PNP KPNA3 KPNA4 DPYSL2 ANK3 FARSB NCAPH RBM39 LRPPRC GTF2I MTHFD1 SNRPD3 RPL4 | 6.61e-07 | 1149 | 212 | 23 | 35446349 |
| Pubmed | ILF3 MPDZ MCM10 DDB1 FASN GLDC DLST TMED10 FUBP3 HSP90AA1 KPNA3 KPNA4 MAT2B IFT74 NUP43 ELP1 FARSB LRPPRC GTF2I TFB1M MTHFD1 WDR87 HADHB SNRPD3 RPL4 | 7.09e-07 | 1335 | 212 | 25 | 29229926 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TRPC4AP ILF3 STAG1 TFIP11 DDB1 PGK1 FASN AHNAK PPP2R3C HSP90AA1 KPNA3 KPNA4 NUP43 DYNC2I1 NAA50 RBM39 LLGL2 GTF2I CDK5RAP2 HADHB SNRPD3 VPS13B STOM | 7.23e-07 | 1155 | 212 | 23 | 20360068 |
| Pubmed | PGK1 FASN AHNAK C3 DLST ILVBL HSP90AA1 FARSB NAA50 LRPPRC GTF2I MTHFD1 RPL4 | 7.46e-07 | 382 | 212 | 13 | 37249651 | |
| Pubmed | SMG1 DDB1 ESYT2 FASN DST AHNAK VPS35L DLST TMED10 FUBP3 ILVBL HSP90AA1 KPNA3 COL5A1 NCAPD3 NUP43 ELP1 FARSB RNF213 NCAPH RBM39 GFM2 LRPPRC GTF2I HADHB SNRPD3 | 8.26e-07 | 1440 | 212 | 26 | 30833792 | |
| Pubmed | ILF3 ACO1 DDB1 ESYT2 GLDC HSP90AA1 FARSB NCAPH RBM39 GFM2 GTF2I MTHFD1 ZNF543 RPL4 | 8.29e-07 | 451 | 212 | 14 | 36168627 | |
| Pubmed | HILI inhibits TGF-β signaling by interacting with Hsp90 and promoting TβR degradation. | 8.89e-07 | 4 | 212 | 3 | 22848678 | |
| Pubmed | STAG1 KDM3B E2F7 DDB1 FASN FUBP3 HSP90AA1 RBM39 LRPPRC GTF2I MARF1 | 1.02e-06 | 272 | 212 | 11 | 31010829 | |
| Pubmed | ILF3 MPDZ DDB1 FASN GLDC FUBP3 HSP90AA1 RBM39 LRPPRC GTF2I RPL4 | 1.10e-06 | 274 | 212 | 11 | 34244482 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 1.17e-06 | 221 | 212 | 10 | 29991511 | |
| Pubmed | ILF3 DDB1 FASN FUBP3 HSP90AA1 KPNA4 FARSB RBM39 LRPPRC GTF2I TFB1M MTHFD1 SNRPD3 RPL4 | 1.31e-06 | 469 | 212 | 14 | 37314180 | |
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | ILF3 DDB1 FASN DLST PISD TMED10 HSP90AA1 FARSB RBM39 GTF2I MTHFD1 HADHB SNRPD3 RPL4 | 1.72e-06 | 480 | 212 | 14 | 25437307 |
| Pubmed | 1.85e-06 | 94 | 212 | 7 | 32062451 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ILF3 ACACB KDM3B HLCS TFIP11 KEAP1 ESYT2 FASN AHNAK CHD6 TMED10 FUBP3 ILVBL HSP90AA1 FARSB NCAPH RBM39 LRPPRC GTF2I MTHFD1 HADHB SNRPD3 RPL4 STOM | 1.95e-06 | 1318 | 212 | 24 | 30463901 |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | ILF3 ACO1 E2F7 TUBA8 DDB1 PGK1 FASN AHNAK ALOX12B HSP90AA1 RNF213 PPM1A HADHB SNRPD3 RPL4 | 1.99e-06 | 558 | 212 | 15 | 27591049 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TRPC4AP DPYSL5 NPHP4 DOCK5 AHNAK WDR35 C3 PISD FYB2 KPNA3 KPNA4 LCA5 ANK3 GOPC IFT74 ATG2B DYNC2I1 CRTC1 LRPPRC NPHP3 GTF2I MARF1 SNRPD3 STOM | 2.03e-06 | 1321 | 212 | 24 | 27173435 |
| Pubmed | LZTR1 NUDT12 ESYT2 PTPRS AHNAK VPS13A HSP90AA1 KPNA3 KPNA4 ANK3 GOPC DUSP1 ELP1 RNF213 NAA50 PPM1A C2CD3 CDK5RAP2 HADHB CKAP2 L3MBTL3 | 2.08e-06 | 1049 | 212 | 21 | 27880917 | |
| Pubmed | mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease. | 2.21e-06 | 5 | 212 | 3 | 32859226 | |
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 22422887 | ||
| Pubmed | ILF3 E2F7 PABPC5 TUBA8 DDB1 PGK1 FASN CHD6 HEATR5B HSP90AA1 KPNA3 KPNA4 FARSB PIP5K1C NCAPH RBM39 LRPPRC GTF2I MTHFD1 HADHB SNRPD3 RPL4 | 2.55e-06 | 1153 | 212 | 22 | 29845934 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ILF3 ACO1 NHLRC2 DDB1 PGK1 FASN DST AHNAK HSP90AA1 PNP ANK3 LRPPRC LLGL2 MTHFD1 DAAM2 HADHB RPL4 STOM | 2.63e-06 | 807 | 212 | 18 | 30575818 |
| Pubmed | ILF3 KEAP1 ESYT2 FASN AHNAK DLST HSP90AA1 NCAPD3 SLC9A8 NAA50 RBM39 LRPPRC GTF2I MTHFD1 HADHB CKAP2 SNRPD3 RPL4 | 2.73e-06 | 809 | 212 | 18 | 32129710 | |
| Pubmed | 2.90e-06 | 191 | 212 | 9 | 33762435 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DOCK5 IGSF10 NUDT12 ADRA1A DST AHNAK MYO3B VPS13A CHD6 FUBP3 DPYSL2 RNF213 PIWIL2 PPM1A MTHFD1 DROSHA PITPNM3 | 3.18e-06 | 736 | 212 | 17 | 29676528 |
| Pubmed | 3.73e-06 | 197 | 212 | 9 | 31620119 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | TRPM7 KEAP1 ADCY3 ESYT2 DST PTPRS ANK3 GOPC PIP5K1C LLGL1 DAAM2 STOM | 3.98e-06 | 377 | 212 | 12 | 38117590 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | TFIP11 PABPC5 MCM10 TUBA8 FASN WDR35 DLST MERTK FUBP3 HSP90AA1 PNP KPNA3 KPNA4 NCAPH LRPPRC GTF2I MTHFD1 CDK5RAP2 HADHB | 4.32e-06 | 922 | 212 | 19 | 27609421 |
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 10956643 | ||
| Pubmed | A role for Fkbp6 and the chaperone machinery in piRNA amplification and transposon silencing. | 4.41e-06 | 6 | 212 | 3 | 22902560 | |
| Pubmed | ILF3 PGK1 MYO3A FASN DST AHNAK FUBP3 HSP90AA1 PNP DPYSL2 ANK3 MAT2B FARSB RNF213 LRPPRC MTHFD1 HADHB SNRPD3 | 4.88e-06 | 844 | 212 | 18 | 25963833 | |
| Pubmed | Fine mapping of collagen-induced arthritis quantitative trait loci in an advanced intercross line. | 6.02e-06 | 20 | 212 | 4 | 17082620 | |
| Pubmed | ILF3 PGK1 FASN AHNAK TMED10 HSP90AA1 PNP DPYSL2 LRPPRC GTF2I MTHFD1 HADHB | 6.71e-06 | 397 | 212 | 12 | 21319273 | |
| Pubmed | ILF3 KDM3B AHNAK FUBP3 PNP GOPC MAT2B IFT74 NUP43 NCAPH GTF2I SNRPD3 | 7.06e-06 | 399 | 212 | 12 | 35987950 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ILF3 STAG1 MPDZ PGK1 PTK2 C3 CHD6 KPNA3 FARSB PIP5K1C RBM39 RPL4 HTT | 8.05e-06 | 475 | 212 | 13 | 31040226 |
| Pubmed | MPDZ TUBA8 ADCY1 ADCY3 ESYT2 GOPC GRM5 PIP5K1C TRIM3 SLC8A1 LLGL1 UNC5C | 8.20e-06 | 405 | 212 | 12 | 38187761 | |
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 9.17e-06 | 79 | 212 | 6 | 26446488 | |
| Pubmed | SMG1 TRPC4AP ACACB KDM3B VPS13A DLST CHD6 BSN PPP2R3C NCAPD3 ELP1 FARSB UNC5C PITPNM3 CDK5RAP2 | 9.95e-06 | 638 | 212 | 15 | 31182584 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ACO1 KDM3B NHLRC2 ARFIP2 DDB1 FASN AHNAK DNMBP FUBP3 HSP90AA1 PNP KPNA3 KPNA4 DPYSL2 GOPC MAT2B NUP43 ELP1 FARSB NCAPH GTF2I MTHFD1 SNRPD3 HTT | 1.03e-05 | 1455 | 212 | 24 | 22863883 |
| Pubmed | TUBA8 PGK1 FASN GLDC FUBP3 HSP90AA1 KPNA3 FARSB NAA50 LRPPRC GTF2I MTHFD1 HADHB SNRPD3 RPL4 | 1.05e-05 | 641 | 212 | 15 | 36057605 | |
| Pubmed | ILF3 ADCY3 PGK1 ESYT2 FASN AHNAK DLST HEATR5B FUBP3 ILVBL HSP90AA1 NCAPD3 FARSB RNF213 NCAPH LRPPRC GTF2I MTHFD1 MARF1 RPL4 STOM | 1.08e-05 | 1168 | 212 | 21 | 19946888 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | ACO1 NPHP4 DDB1 PGK1 ABCA8 WDR35 C3 HSP90AA1 DPYSL2 CCIN NPHP3 MROH1 HADHB CDH2 | 1.08e-05 | 564 | 212 | 14 | 21565611 |
| Pubmed | ACACB KEAP1 FASN DST AHNAK CHD6 IFT74 ATG2B CRTC1 GTF2I LRP1 L3MBTL3 | 1.12e-05 | 418 | 212 | 12 | 34709266 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ACO1 KDM3B KEAP1 DDB1 PGK1 ESYT2 FASN AHNAK DLST TMED10 FUBP3 ILVBL HSP90AA1 DPYSL2 IFT74 RNF213 DPYSL4 NAA50 NCAPH RBM39 LRPPRC LRP1 SNRPD3 | 1.17e-05 | 1367 | 212 | 23 | 32687490 |
| Pubmed | TRPM7 NHLRC2 ARFIP2 ESYT2 FASN DST AHNAK VPS13A HSP90AA1 DPYSL2 GOPC ATG2B VPS13B STOM | 1.17e-05 | 568 | 212 | 14 | 37774976 | |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 1.18e-05 | 287 | 212 | 10 | 36180891 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ILF3 DPYSL5 TFIP11 DDB1 DST DLST CHD6 HSDL1 HSP90AA1 KPNA3 DPYSL2 DPYSL4 RBM39 LRPPRC LLGL1 DROSHA HADHB CATSPERG SNRPD3 RPL4 | 1.18e-05 | 1082 | 212 | 20 | 38697112 |
| Pubmed | ACACB ESYT2 DST PCDH19 ANK3 GOPC LRPPRC LLGL2 LLGL1 TFB1M UNC5C CDH2 | 1.21e-05 | 421 | 212 | 12 | 36976175 | |
| Pubmed | CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. | 1.22e-05 | 8 | 212 | 3 | 12134159 | |
| Pubmed | SMG1 KDM3B MPDZ TFIP11 PTK2 DOCK5 DST HSDL1 ILVBL NCAPD3 ELP1 LLGL2 LLGL1 DROSHA MARF1 | 1.24e-05 | 650 | 212 | 15 | 38777146 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | TRPC4AP DDB1 PGK1 FASN HSP90AA1 KPNA3 ELP1 RNF213 PPM1A LRPPRC HADHB SNRPD3 RPL4 | 1.25e-05 | 495 | 212 | 13 | 28581483 |
| Pubmed | KDM3B HLCS MPDZ TFIP11 NHLRC2 MCM10 DDB1 NUDT12 CHD6 TMED10 DPYSL2 GOPC DYNC2I1 RNF213 NUS1 CKAP2 | 1.26e-05 | 733 | 212 | 16 | 34672954 | |
| Pubmed | MPDZ FAM13B DDB1 PGK1 DOCK5 AHNAK DNMBP FUBP3 GOPC MAT2B FASTKD1 PIP5K1C RBM39 PLEKHG4B TFB1M HADHB STOM SOS2 | 1.47e-05 | 916 | 212 | 18 | 32203420 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | PGK1 FASN AHNAK DLST HSP90AA1 NAA50 RBM39 LRPPRC MTHFD1 HADHB SNRPD3 RPL4 CDH13 STOM | 1.48e-05 | 580 | 212 | 14 | 35676659 |
| Pubmed | 1.49e-05 | 234 | 212 | 9 | 36243803 | ||
| Pubmed | TRPM7 ATG2A ARFIP2 ESYT2 DST VPS35L VPS13A HEATR5B GOPC ATG2B HPS3 VPS13B STOM | 1.50e-05 | 504 | 212 | 13 | 34432599 | |
| Pubmed | KDM3B KEAP1 FASN DST AHNAK C3 PISD TMED10 ILVBL HSP90AA1 PNP KPNA3 KPNA4 COL5A1 DPYSL2 GOPC FARSB LRPPRC MTHFD1 HADHB RPL4 STOM | 1.61e-05 | 1297 | 212 | 22 | 33545068 | |
| Pubmed | 1.65e-05 | 52 | 212 | 5 | 9455477 | ||
| Pubmed | 1.82e-05 | 53 | 212 | 5 | 18174230 | ||
| Pubmed | DDB1 GLDC KPNA3 KPNA4 DPYSL2 ANK3 SEPTIN5 RNF213 LRPPRC CDH2 | 1.94e-05 | 304 | 212 | 10 | 32235678 | |
| Pubmed | Same but different - Molecular comparison of human KTI12 and PSTK. | 2.11e-05 | 27 | 212 | 4 | 33417976 | |
| Pubmed | 2.36e-05 | 248 | 212 | 9 | 32963011 | ||
| Pubmed | FASN AHNAK TMED10 HSP90AA1 DPYSL2 FARSB LRPPRC MTHFD1 HADHB RPL4 | 2.42e-05 | 312 | 212 | 10 | 37120454 | |
| Pubmed | ACACB LRP1B PGK1 ESYT2 DLST BSN HSP90AA1 DPYSL2 ANK3 GOPC SEPTIN5 ATG2B CPZ GRM5 RBM39 LRPPRC MTHFD1 PITPNM3 HADHB MTX1 | 2.46e-05 | 1139 | 212 | 20 | 36417873 | |
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 2.60e-05 | 10 | 212 | 3 | 11884542 | |
| Pubmed | 3.12e-05 | 257 | 212 | 9 | 16335952 | ||
| Pubmed | MPDZ PKD1L2 ADCY3 DST ANKRD12 PPP2R3C DPYSL2 RBM39 MARF1 CDH13 | 3.16e-05 | 322 | 212 | 10 | 26514267 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ILF3 KEAP1 DDB1 PGK1 FASN DST AHNAK C3 DLST PISD HSP90AA1 FARSB NCAPH RBM39 LRPPRC GTF2I MTHFD1 HADHB CKAP2 SNRPD3 RPL4 | 3.17e-05 | 1257 | 212 | 21 | 36526897 |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 3.21e-05 | 258 | 212 | 9 | 21081666 | |
| Pubmed | ILF3 DDB1 FASN C3 DLST HEPHL1 FUBP3 DPYSL2 GFM2 LRPPRC HADHB MTX1 SNRPD3 RPL4 STOM | 3.48e-05 | 711 | 212 | 15 | 33022573 | |
| Pubmed | 3.55e-05 | 11 | 212 | 3 | 37085665 | ||
| Pubmed | KDM3B MPDZ TFIP11 KEAP1 FASN AHNAK DPYSL2 ANK3 IFT74 ATG2B NCAPH GTF2I HTT | 3.65e-05 | 549 | 212 | 13 | 38280479 | |
| Pubmed | Expression and Regulation of PIWIL-Proteins and PIWI-Interacting RNAs in Rheumatoid Arthritis. | 3.70e-05 | 2 | 212 | 2 | 27893851 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 3.70e-05 | 2 | 212 | 2 | 15963947 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 28800131 | ||
| Pubmed | Expression of human Piwi-like genes is associated with prognosis for soft tissue sarcoma patients. | 3.70e-05 | 2 | 212 | 2 | 22748119 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 33159041 | ||
| Pubmed | Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome. | 3.70e-05 | 2 | 212 | 2 | 25795793 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 22219374 | ||
| Interaction | HSP90AA1 interactions | SMG1 ILF3 KEAP1 NPHP4 MAP3K12 PGK1 PTK2 DOCK5 FASN GLDC MYO3B C3 MERTK WNK4 HSP90AA1 TRIM2 RAPSN PIWIL2 PPARA ACVR1C RBM39 CCIN TGFBR1 LRPPRC LLGL1 MTHFD1 WDR87 LRP1 MAST1 RPL4 HTT SBK2 | 3.04e-06 | 1263 | 211 | 32 | int:HSP90AA1 |
| GeneFamily | Myosins, class III|Deafness associated genes | 6.48e-05 | 2 | 146 | 2 | 1099 | |
| GeneFamily | Fibronectin type III domain containing | 3.23e-04 | 160 | 146 | 7 | 555 | |
| GeneFamily | Membrane associated guanylate kinases|PDZ domain containing|Scribble complex | 3.84e-04 | 4 | 146 | 2 | 1224 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 1.32e-03 | 7 | 146 | 2 | 345 | |
| GeneFamily | Argonaute/PIWI family | 1.76e-03 | 8 | 146 | 2 | 408 | |
| GeneFamily | Classical BAR domain containing | 1.76e-03 | 8 | 146 | 2 | 1292 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.98e-03 | 161 | 146 | 6 | 593 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.79e-03 | 10 | 146 | 2 | 53 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN | KDM3B PTK2 FASN AHNAK PISD ILVBL PNP LRPPRC MTHFD1 PDZK1IP1 HADHB | 7.64e-07 | 200 | 212 | 11 | M5212 |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN | AHNAK BSN KPNA3 NCAPD3 SLC25A42 ANK3 ACVR1C LHX6 VPS13B STOM | 5.73e-06 | 200 | 212 | 10 | M6789 |
| Coexpression | GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN | 1.00e-05 | 128 | 212 | 8 | M410 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ABCA8 PTK2 DOCK5 DST MYRF CNTN2 DPYSL2 TRIM2 ANK3 APLP1 TTLL7 DAAM2 | 2.33e-10 | 199 | 212 | 12 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ABCA8 PTK2 DOCK5 DST MYRF CNTN2 DPYSL2 TRIM2 ANK3 APLP1 TTLL7 DAAM2 | 2.46e-10 | 200 | 212 | 12 | acdef0b9096c774040948fc75621ff2b08ea2ee8 |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | ADCY3 ADRA1A COL4A1 COL5A1 ANK3 FAT3 THBS2 SLC8A1 UNC5C DAAM2 CDH13 | 2.16e-09 | 191 | 212 | 11 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ABCA8 PTK2 DOCK5 MYRF CNTN2 DPYSL2 TRIM2 ANK3 APLP1 TTLL7 DAAM2 | 3.49e-09 | 200 | 212 | 11 | 091a18d6efed81cab99955c3047f172170f70476 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ABCA8 PTK2 DOCK5 MYRF CNTN2 DPYSL2 TRIM2 ANK3 APLP1 TTLL7 DAAM2 | 3.49e-09 | 200 | 212 | 11 | 3b8513defe25262ab4b492345b2628570eaefd17 |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CHL1 ADCY1 SLITRK2 SLC25A42 ANK3 DPYSL4 HPS3 TFB1M CDH2 L3MBTL3 | 1.66e-08 | 180 | 212 | 10 | da723df348d7b8449bb1124f23fe6fa706412adb |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CHL1 ADCY1 SLITRK2 SLC25A42 ANK3 DPYSL4 HPS3 TFB1M CDH2 L3MBTL3 | 1.66e-08 | 180 | 212 | 10 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CHL1 ADCY1 SLITRK2 SLC25A42 ANK3 DPYSL4 HPS3 TFB1M CDH2 L3MBTL3 | 1.66e-08 | 180 | 212 | 10 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.04e-08 | 184 | 212 | 10 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.06e-08 | 192 | 212 | 10 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | DPYSL5 ABCA8 DOCK5 MYRF CNTN2 DPYSL2 TRIM2 APLP1 TTLL7 LLGL1 | 3.06e-08 | 192 | 212 | 10 | 8dc3016601148243196e925641c9507e9d58c9e0 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.72e-08 | 196 | 212 | 10 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.29e-08 | 199 | 212 | 10 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.29e-08 | 199 | 212 | 10 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.29e-08 | 199 | 212 | 10 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.29e-08 | 199 | 212 | 10 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.50e-08 | 200 | 212 | 10 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.50e-08 | 200 | 212 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.50e-08 | 200 | 212 | 10 | 829978708463a7459fe1041bd90196775bc4b531 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.50e-08 | 200 | 212 | 10 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 2.47e-07 | 183 | 212 | 9 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.71e-07 | 185 | 212 | 9 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.10e-07 | 188 | 212 | 9 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.25e-07 | 189 | 212 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.39e-07 | 190 | 212 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.39e-07 | 190 | 212 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.55e-07 | 191 | 212 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 3.71e-07 | 192 | 212 | 9 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.04e-07 | 194 | 212 | 9 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.04e-07 | 194 | 212 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.22e-07 | 195 | 212 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-07 | 195 | 212 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-07 | 195 | 212 | 9 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.41e-07 | 196 | 212 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.60e-07 | 197 | 212 | 9 | 032ccc91e604113da9bc34a6f9ddb1d45dea1892 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.80e-07 | 198 | 212 | 9 | bdabdb11217ea16e5863aa6bfb0f04d48b17f81e | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.80e-07 | 198 | 212 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.01e-07 | 199 | 212 | 9 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.22e-07 | 200 | 212 | 9 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.22e-07 | 200 | 212 | 9 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.22e-07 | 200 | 212 | 9 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-07 | 200 | 212 | 9 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.22e-07 | 200 | 212 | 9 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.22e-07 | 200 | 212 | 9 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-07 | 200 | 212 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-07 | 200 | 212 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.22e-07 | 200 | 212 | 9 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.22e-07 | 200 | 212 | 9 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.22e-07 | 200 | 212 | 9 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.22e-07 | 200 | 212 | 9 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.98e-07 | 152 | 212 | 8 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-06 | 123 | 212 | 7 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-06 | 177 | 212 | 8 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.19e-06 | 177 | 212 | 8 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 2.29e-06 | 178 | 212 | 8 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 2.48e-06 | 180 | 212 | 8 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 2.48e-06 | 180 | 212 | 8 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.59e-06 | 181 | 212 | 8 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 2.81e-06 | 183 | 212 | 8 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.17e-06 | 186 | 212 | 8 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.30e-06 | 187 | 212 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.30e-06 | 187 | 212 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 3.43e-06 | 188 | 212 | 8 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 3.57e-06 | 189 | 212 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-06 | 189 | 212 | 8 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.71e-06 | 190 | 212 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-06 | 190 | 212 | 8 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.71e-06 | 190 | 212 | 8 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 191 | 212 | 8 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.86e-06 | 191 | 212 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.01e-06 | 192 | 212 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.01e-06 | 192 | 212 | 8 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.16e-06 | 193 | 212 | 8 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.16e-06 | 193 | 212 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.16e-06 | 193 | 212 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-06 | 194 | 212 | 8 | ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-06 | 194 | 212 | 8 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | Differ-Basal|World / shred by cell class for mouse tongue | 4.33e-06 | 194 | 212 | 8 | 851eff82c9f3d44c86e3e127a804bbd1fced6a7c | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 195 | 212 | 8 | 841fde528ecb293e07b5e00e499d1e9f0b0dce14 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.49e-06 | 195 | 212 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.49e-06 | 195 | 212 | 8 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 4.49e-06 | 195 | 212 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-06 | 196 | 212 | 8 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.66e-06 | 196 | 212 | 8 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.66e-06 | 196 | 212 | 8 | 77feb22fd0b0b1df03375da472134412e9e69c90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.84e-06 | 197 | 212 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-06 | 197 | 212 | 8 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-06 | 197 | 212 | 8 | e6cbfa267eb2e05b441fd034786faae07bb0e081 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.84e-06 | 197 | 212 | 8 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.84e-06 | 197 | 212 | 8 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-06 | 197 | 212 | 8 | 69d5b8588046d119b5dff9a7fd6f49e97e00a5b7 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.03e-06 | 198 | 212 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.03e-06 | 198 | 212 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.22e-06 | 199 | 212 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-06 | 199 | 212 | 8 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.22e-06 | 199 | 212 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 5.22e-06 | 199 | 212 | 8 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| Drug | Methamphetamine | HDAC9 ACACB ACO1 DPYSL5 NHLRC2 MCM10 ADCY3 PGK1 DST PTPRS AHNAK DLST PLK3 CNTN2 CHAC1 HSP90AA1 KPNA4 DPYSL2 SLC9A8 SEPTIN5 DUSP1 ELP1 CPZ GRM5 TGFBR1 RASGRP1 PROX2 LRP1 PNPLA7 CKAP2 CDH13 HDC | 2.33e-06 | 1401 | 212 | 32 | ctd:D008694 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.05e-06 | 148 | 206 | 9 | C0279702 | |
| Disease | brain cancer (implicated_via_orthology) | 3.06e-05 | 26 | 206 | 4 | DOID:1319 (implicated_via_orthology) | |
| Disease | age-related macular degeneration | 3.86e-05 | 89 | 206 | 6 | EFO_0001365 | |
| Disease | IGF-1 measurement | ACACB EPHA6 STAG1 DPYSL5 ADCY1 CCDC33 RAPSN ELP1 PIWIL4 PPARA GRM5 LRPPRC SLC8A1 | 4.30e-05 | 488 | 206 | 13 | EFO_0004627 |
| Disease | Ritscher-Schinzel syndrome (is_implicated_in) | 4.85e-05 | 2 | 206 | 2 | DOID:0060565 (is_implicated_in) | |
| Disease | parietal cortex measurement, white matter microstructure measurement | 4.85e-05 | 2 | 206 | 2 | EFO_0005674, EFO_0008420 | |
| Disease | parental longevity | PKD1L2 LRP1B FAM13B RYR3 VPS13A TMED10 BSN COL4A1 GRM5 PROX2 CDH2 CDH13 HTT | 4.87e-05 | 494 | 206 | 13 | EFO_0007796 |
| Disease | Fetal Alcohol Spectrum Disorders | 9.11e-05 | 13 | 206 | 3 | C2985290 | |
| Disease | coronary artery disease | HDAC9 TRPC4AP STAG1 TRPM7 ABCA8 DOCK5 IGSF10 C2 PLCB2 TMED10 MERTK BSN COL4A1 SLC9A8 SEPTIN5 RNF213 PPM1A NUS1 UNC5C LRP1 CDH13 | 1.02e-04 | 1194 | 206 | 21 | EFO_0001645 |
| Disease | cardiotoxicity, response to anthracycline-based chemotherapy | 1.15e-04 | 14 | 206 | 3 | EFO_0005257, EFO_1001482 | |
| Disease | Saldino-Noonan Syndrome | 1.15e-04 | 14 | 206 | 3 | C0036069 | |
| Disease | Cohen syndrome (implicated_via_orthology) | 1.45e-04 | 3 | 206 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology) | 1.45e-04 | 3 | 206 | 2 | DOID:0110274 (implicated_via_orthology) | |
| Disease | Skeletal dysplasia | 1.45e-04 | 3 | 206 | 2 | C0410528 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology) | 1.45e-04 | 3 | 206 | 2 | DOID:0110282 (implicated_via_orthology) | |
| Disease | major depressive disorder (implicated_via_orthology) | 1.45e-04 | 3 | 206 | 2 | DOID:1470 (implicated_via_orthology) | |
| Disease | sphingolipid measurement | 1.73e-04 | 40 | 206 | 4 | EFO_0004622 | |
| Disease | Moyamoya disease | 1.73e-04 | 40 | 206 | 4 | MONDO_0016820 | |
| Disease | Fetal Alcohol Syndrome | 2.12e-04 | 17 | 206 | 3 | C0015923 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 2.45e-04 | 295 | 206 | 9 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | cholesteryl ester 20:5 measurement | 2.52e-04 | 44 | 206 | 4 | EFO_0010349 | |
| Disease | apolipoprotein B measurement | ACACB STAG1 DPYSL5 NHLRC2 ABCA8 PTK2 PISD MYRF RAPSN ACVR1C NPHP3 LLGL1 L3MBTL3 HTT | 2.53e-04 | 663 | 206 | 14 | EFO_0004615 |
| Disease | diastolic blood pressure, systolic blood pressure | HDAC9 ADCY1 DOCK5 CHD6 COL4A1 RAPSN ANK3 RASGRP1 THBS2 C2CD3 PDZK1IP1 LRP1 CDH2 CDH13 | 2.82e-04 | 670 | 206 | 14 | EFO_0006335, EFO_0006336 |
| Disease | Renal Cell Carcinoma | 2.88e-04 | 128 | 206 | 6 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.88e-04 | 128 | 206 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.88e-04 | 128 | 206 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.88e-04 | 128 | 206 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.88e-04 | 128 | 206 | 6 | C1306837 | |
| Disease | prion disease, Atypical behavior | 2.88e-04 | 4 | 206 | 2 | EFO_0004720, HP_0000708 | |
| Disease | phosphatidylcholine (18:0/20:2, 20:0/18:2) measurement | 2.88e-04 | 4 | 206 | 2 | EFO_0800488 | |
| Disease | Alzheimer's disease (is_implicated_in) | 3.40e-04 | 132 | 206 | 6 | DOID:10652 (is_implicated_in) | |
| Disease | Infiltrating duct carcinoma of female breast | 4.06e-04 | 21 | 206 | 3 | C3165106 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 4.06e-04 | 21 | 206 | 3 | OBA_2045076 | |
| Disease | serum alanine aminotransferase measurement | CHL1 STAG1 TRPM7 AHNAK PISD HEPHL1 MERTK DNMBP MYRF PNP RAPSN PIWIL4 MARF1 L3MBTL3 HTT SOS2 | 4.27e-04 | 869 | 206 | 16 | EFO_0004735 |
| Disease | neuroblastoma (implicated_via_orthology) | 4.78e-04 | 5 | 206 | 2 | DOID:769 (implicated_via_orthology) | |
| Disease | muscular disease (implicated_via_orthology) | 4.78e-04 | 5 | 206 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Short rib-polydactyly syndrome, Verma-Naumoff type | 4.78e-04 | 5 | 206 | 2 | C0432197 | |
| Disease | level of Phosphatidylcholine (16:0_20:1) in blood serum | 4.78e-04 | 5 | 206 | 2 | OBA_2045073 | |
| Disease | level of Phosphatidylcholine (18:0_22:6) in blood serum | 4.78e-04 | 5 | 206 | 2 | OBA_2045097 | |
| Disease | nisinate (24:6n3) measurement | 4.78e-04 | 5 | 206 | 2 | EFO_0800536 | |
| Disease | frailty measurement | 5.36e-04 | 23 | 206 | 3 | EFO_0009885 | |
| Disease | Ovarian Serous Adenocarcinoma | 5.36e-04 | 23 | 206 | 3 | C1335177 | |
| Disease | Hepatomegaly | 5.55e-04 | 54 | 206 | 4 | C0019209 | |
| Disease | insulin measurement | 6.08e-04 | 267 | 206 | 8 | EFO_0004467 | |
| Disease | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | 6.09e-04 | 24 | 206 | 3 | EFO_0006821, EFO_0006826 | |
| Disease | cancer (implicated_via_orthology) | 6.23e-04 | 268 | 206 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | Dwarfism | 6.89e-04 | 25 | 206 | 3 | C0013336 | |
| Disease | 1-arachidonylglycerol (20:4) measurement | 7.14e-04 | 6 | 206 | 2 | EFO_0800224 | |
| Disease | level of Phosphatidylethanolamine (O-16:1_20:4) in blood serum | 7.14e-04 | 6 | 206 | 2 | OBA_2045145 | |
| Disease | lysophosphatidylcholine 18:3 measurement | 7.14e-04 | 6 | 206 | 2 | EFO_0021454 | |
| Disease | gondoic acid measurement | 7.14e-04 | 6 | 206 | 2 | EFO_0007975 | |
| Disease | level of Phosphatidylcholine (16:1_20:4) in blood serum | 7.14e-04 | 6 | 206 | 2 | OBA_2045084 | |
| Disease | nephronophthisis (is_implicated_in) | 7.14e-04 | 6 | 206 | 2 | DOID:12712 (is_implicated_in) | |
| Disease | 1-arachidonoylglycerophosphocholine measurement | 7.14e-04 | 6 | 206 | 2 | EFO_0021076 | |
| Disease | 1-linoleoylglycerophosphoethanolamine measurement | 7.14e-04 | 6 | 206 | 2 | EFO_0021084 | |
| Disease | arachidonoylcholine measurement | 7.14e-04 | 6 | 206 | 2 | EFO_0800478 | |
| Disease | 1-docosapentaenoyl-GPC (22:5n3) measurement | 7.14e-04 | 6 | 206 | 2 | EFO_0800298 | |
| Disease | level of Phosphatidylcholine (17:0_20:4) in blood serum | 7.74e-04 | 26 | 206 | 3 | OBA_2045087 | |
| Disease | mean arterial pressure | HDAC9 HLCS NHLRC2 RHBDL3 DLST MERTK COL5A1 RNF213 PROX2 MTX1 CABCOCO1 | 8.20e-04 | 499 | 206 | 11 | EFO_0006340 |
| Disease | myocardial infarction | 8.39e-04 | 350 | 206 | 9 | EFO_0000612 | |
| Disease | ER membrane protein complex subunit 4 measurement | 9.95e-04 | 7 | 206 | 2 | EFO_0801580 | |
| Disease | level of Phosphatidylcholine (18:2_20:4) in blood serum | 9.95e-04 | 7 | 206 | 2 | OBA_2045109 | |
| Disease | level of Phosphatidylcholine (O-18:2_20:4) in blood serum | 9.95e-04 | 7 | 206 | 2 | OBA_2045135 | |
| Disease | eicosapentaenoate (EPA; 20:5n3) measurement | 9.95e-04 | 7 | 206 | 2 | EFO_0800616 | |
| Disease | arachidonate 20:4n6 measurement | 9.95e-04 | 7 | 206 | 2 | EFO_0021063 | |
| Disease | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) measurement | 9.95e-04 | 7 | 206 | 2 | EFO_0800391 | |
| Disease | retinal detachment | 9.95e-04 | 7 | 206 | 2 | EFO_0005773 | |
| Disease | 1-eicosapentaenoyl-GPE (20:5) measurement | 9.95e-04 | 7 | 206 | 2 | EFO_0800353 | |
| Disease | MASA syndrome (implicated_via_orthology) | 9.95e-04 | 7 | 206 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | sleep duration | 1.06e-03 | 362 | 206 | 9 | EFO_0005271 | |
| Disease | Crohn's disease | 1.14e-03 | 441 | 206 | 10 | EFO_0000384 | |
| Disease | Myopathy | 1.18e-03 | 30 | 206 | 3 | C0026848 | |
| Disease | Mood Disorders | 1.20e-03 | 168 | 206 | 6 | C0525045 | |
| Disease | Grand Mal Status Epilepticus | 1.25e-03 | 67 | 206 | 4 | C0311335 | |
| Disease | Petit mal status | 1.25e-03 | 67 | 206 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 1.25e-03 | 67 | 206 | 4 | C0393734 | |
| Disease | Status Epilepticus, Subclinical | 1.25e-03 | 67 | 206 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 1.25e-03 | 67 | 206 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 1.25e-03 | 67 | 206 | 4 | C0751523 | |
| Disease | Microcephaly | 1.25e-03 | 67 | 206 | 4 | C0025958 | |
| Disease | level of Phosphatidylcholine (18:0_20:4) in blood serum | 1.31e-03 | 31 | 206 | 3 | OBA_2045094 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_18:2) in blood serum | 1.32e-03 | 8 | 206 | 2 | OBA_2045147 | |
| Disease | level of Phosphatidylethanolamine (O-18:2_20:4) in blood serum | 1.32e-03 | 8 | 206 | 2 | OBA_2045151 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.32e-03 | 8 | 206 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)) measurement | 1.32e-03 | 8 | 206 | 2 | EFO_0800583 | |
| Disease | stearidonate 18:4n3 measurement | 1.32e-03 | 8 | 206 | 2 | EFO_0021075 | |
| Disease | 1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6) measurement | 1.32e-03 | 8 | 206 | 2 | EFO_0800392 | |
| Disease | 1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6) measurement | 1.32e-03 | 8 | 206 | 2 | EFO_0800450 | |
| Disease | Status Epilepticus | 1.33e-03 | 68 | 206 | 4 | C0038220 | |
| Disease | phosphatidylethanolamine measurement | 1.40e-03 | 173 | 206 | 6 | EFO_0010228 | |
| Disease | metabolite measurement, diet measurement | 1.56e-03 | 71 | 206 | 4 | EFO_0004725, EFO_0008111 | |
| Disease | phosphatidylcholine 38:5 measurement | 1.57e-03 | 33 | 206 | 3 | EFO_0010387 | |
| Disease | non-high density lipoprotein cholesterol measurement | NHLRC2 KEAP1 ESYT2 C2 MYRF TRIM2 RAPSN RNF135 PPARA ACVR1C PROX2 MTX1 L3MBTL3 | 1.60e-03 | 713 | 206 | 13 | EFO_0005689 |
| Disease | 1-arachidonoyl-GPE (20:4n6) measurement | 1.69e-03 | 9 | 206 | 2 | EFO_0800248 | |
| Disease | level of Phosphatidylcholine (O-18:0_20:4) in blood serum | 1.69e-03 | 9 | 206 | 2 | OBA_2045127 | |
| Disease | level of Phosphatidylcholine (O-18:1_18:2) in blood serum | 1.69e-03 | 9 | 206 | 2 | OBA_2045129 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:3) in blood serum | 1.69e-03 | 9 | 206 | 2 | OBA_2045130 | |
| Disease | level of Phosphatidylcholine (16:0_20:5) in blood serum | 1.69e-03 | 9 | 206 | 2 | OBA_2045077 | |
| Disease | level of Phosphatidylcholine (18:0_20:5) in blood serum | 1.69e-03 | 9 | 206 | 2 | OBA_2045095 | |
| Disease | Nephronophthisis | 1.69e-03 | 9 | 206 | 2 | cv:C0687120 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERIHRSNLVGMGVIP | 801 | P21399 | |
| EDLVRMGHLTGLKPL | 111 | Q6ZRH7 | |
| IHGTMRVILEPLIGD | 296 | A0FGR8 | |
| LGEVMAEIGPTHSQK | 36 | Q8IVU9 | |
| IPMDGTAVITKGDRH | 411 | Q13939 | |
| KGLDGLHVERLPIMD | 531 | Q8N5R6 | |
| EKRENVMFVLPLHGG | 361 | P08910 | |
| AVEGQHKDMVRIPVG | 366 | P35348 | |
| VPHEINKVLGEMTEL | 316 | O95267 | |
| LHMEIVGTQGKPAIA | 306 | Q8NER5 | |
| KIPLDHGTLLIMEGA | 236 | Q96Q83 | |
| PGEISEHEGFLRAKM | 301 | P51693 | |
| VLDGEHRTPLMKALQ | 101 | Q9BXX3 | |
| VPGQQMTLKIEGDHG | 576 | P01024 | |
| VGQMHVTKLAEPLEI | 186 | Q86Y34 | |
| VKMEGGGAEVHAQLP | 5246 | Q09666 | |
| ETLEKEGPGHMGRSL | 671 | Q6XZF7 | |
| VEQKAESVGRIMPHT | 426 | Q96CM8 | |
| TMEIPIHGNGEARQL | 11 | P53365 | |
| ETPLHMAAIRGDVKQ | 186 | Q6UB98 | |
| PHAEDMAELVIVGGK | 101 | P55290 | |
| VAGGVELMSDVPIRH | 161 | P55084 | |
| LLGGMRNQIVPDAHK | 1911 | Q2TAZ0 | |
| VGPMHSLVQLVQGLK | 1891 | Q96BY7 | |
| DLGPGHVRIKIRMDI | 456 | Q8IZY2 | |
| HQKLILAEAVMEGRP | 986 | Q96SN8 | |
| KAILAGAQPIEEMRH | 486 | Q8WWK9 | |
| EILGHVPGMLLKGER | 161 | P02462 | |
| DVRQGTMPVSLLKAH | 246 | Q8NFH3 | |
| KAVVLMSHLGRPDGV | 56 | P07205 | |
| HPGEVLVMLVGNKTD | 121 | Q9H0T7 | |
| LAGRPMKVGHVTERT | 316 | Q14498 | |
| NITKHGERILGVGME | 356 | Q9H8K7 | |
| ESMKIALQHGDRPLQ | 231 | Q13702 | |
| GHVNIVEPSLMLLKG | 196 | O75747 | |
| IQLLGRDMKGPAHDK | 221 | Q9HD26 | |
| AVLGKEVQLMHRAPV | 776 | Q15334 | |
| VGMKLEGVDPEHQSV | 266 | Q96JM7 | |
| RAIQELMKIHGQDPV | 371 | Q969Q6 | |
| HDTPGRMLEKGVISD | 2301 | O00763 | |
| GHFELRKNGTMPREV | 216 | Q9H765 | |
| VMHEVSPILKEGRNK | 1121 | Q8TAB3 | |
| AGPMKRENGLHLETL | 531 | P19113 | |
| MLGIQPVIDKLRQHE | 306 | Q86T65 | |
| VLVMTVRPEDHGAQL | 301 | O60500 | |
| TLGIPMLKIVFAGHE | 281 | Q0GE19 | |
| DAGLIPMIIHQLAKG | 366 | O00505 | |
| RVVAHMPGDIIIGAL | 26 | P41594 | |
| RKTLLEGEMSHPRGI | 636 | Q9NZR2 | |
| HEGIRGIPLEPSDKM | 1886 | Q9NZR2 | |
| PRKGHVEDVLLIMDV | 536 | Q8N653 | |
| MVGREKELSIHFVPG | 1 | Q9NZL9 | |
| KEIQLMHRAPVVGIL | 766 | Q6P1M3 | |
| LGNTKMELLHPLGRD | 91 | Q96PE7 | |
| VFEPGAEHIVRLMTK | 1036 | O00533 | |
| MKDFSHPNVIRLLGV | 641 | Q12866 | |
| VPGGVKTIEAHSRMV | 51 | Q16555 | |
| KTIEAHSRMVIPGGI | 56 | Q16555 | |
| GGLPETAKEQLNVHM | 6516 | Q03001 | |
| VVGTPHGRDVNVMAK | 541 | Q8IYT1 | |
| MPGLKGFVDEHTINI | 261 | Q07954 | |
| DRGVTHLNISGLKMP | 3946 | Q07954 | |
| HLNISGLKMPRGIAI | 3951 | Q07954 | |
| MGGSPKTAVDHIREI | 381 | P06681 | |
| RGQMLQPIIEGETAH | 766 | Q9NYF5 | |
| GARKPHTVVVQMGEG | 1856 | Q9UPA5 | |
| DKDRMIVHVPFGTRG | 311 | P50747 | |
| AAMRHQGKIPEELSL | 71 | Q9C098 | |
| SDLGLMPGGRVKLVH | 826 | Q8WVS4 | |
| MPGGRVKLVHSALIQ | 831 | Q8WVS4 | |
| AAIVVNGHGMTPLKV | 211 | Q9UK73 | |
| GNMVQGKELPLLHRV | 71 | Q5VYM1 | |
| MKGSRIELGDVTPHN | 1 | Q9GZZ1 | |
| PAHMILTVGNKADGV | 61 | Q13113 | |
| GRSLEKLPVHMGLVI | 91 | Q96E22 | |
| PVGMKAEGFVDALHR | 11 | Q96I24 | |
| QQPLGATIKRHEMTG | 161 | Q96JB8 | |
| SGEIKSVDPRLIHVM | 236 | Q7LBC6 | |
| HGEAGILNPIMEREE | 376 | Q86VQ0 | |
| VHLKADMDGPLSNRG | 341 | Q9UPM6 | |
| ILKGMQELGVHPDQE | 461 | P42704 | |
| FKDPTGEMQGTVHRL | 516 | Q8N3J3 | |
| KLVLQMPRGNLEVVH | 706 | O95163 | |
| APMIIHGIKTQGARQ | 2096 | P00451 | |
| SIDHPQKVLIMGEAL | 371 | Q7L590 | |
| KSVVLMSHLGRPDGV | 56 | P00558 | |
| DKVRTHGPQLLTAMI | 1396 | Q8NDA8 | |
| LVMSKGHRIEEVPEL | 136 | P36578 | |
| EIMRKQPTVVLGVAH | 561 | Q6ZV29 | |
| VKHLVGGERDPMNLF | 446 | Q8NBF2 | |
| PGMEITKDGFHLVIE | 141 | Q6UXL0 | |
| AEEHVKMVRSGGIPV | 176 | Q6UXL0 | |
| MVHPEVVELILKSGN | 1031 | Q9Y2H9 | |
| DMLGFGRVKPIGVHS | 801 | O75161 | |
| KLMGPGRHRLEIQAT | 416 | Q7Z442 | |
| QKLAQVEPGEHVTGM | 1666 | Q13332 | |
| MNGRIVGSKPLHVTL | 361 | Q96DU9 | |
| MHGIFDRPVAIGGKV | 396 | P36957 | |
| LLPSVKMEQRGLHAV | 411 | Q3B8N5 | |
| VLHLPQMGDQDGKRE | 46 | Q9UBC7 | |
| VPGGIKTIDAHGLMV | 51 | O14531 | |
| ANVMEAAGLPGKVHI | 426 | Q08828 | |
| AILPHVISRMGKLEQ | 3071 | P42858 | |
| SVKMKGQRPLEHDGE | 661 | Q6WRI0 | |
| KVAHRPVTQQGLTGM | 66 | Q96LB3 | |
| PEINKDRMHLILGVS | 1581 | Q9P2D3 | |
| RHKIPVMALVGNDAG | 536 | A1L0T0 | |
| DGGLPHGLELMQKIV | 1346 | Q4AC94 | |
| PQAQGGLLETREKMH | 1336 | Q6ZP82 | |
| LMEPEVKLIGNIHGN | 236 | Q66K79 | |
| TMGNRASIPLKDIHV | 641 | Q96AV8 | |
| QMPLLTEGIRIHGEK | 1596 | Q9H7D0 | |
| AKGAMGLEHIVPNAE | 56 | P28562 | |
| MVGGTPHNILDFIKE | 231 | Q7Z4J2 | |
| AVGMGERPEVLHLTE | 1881 | Q8TD26 | |
| HQKRVLLLTVPGMEE | 176 | Q6UUV9 | |
| KMPGRVVTLLEDHEG | 76 | Q9BUX1 | |
| NPQKLMVLIHGSGVV | 146 | Q8WUF8 | |
| PGGVIGKIHATDQDM | 3566 | Q8TDW7 | |
| PLMGKIADIVHRNLE | 171 | Q53R41 | |
| HVAVKVLQDMGLPTG | 456 | Q12906 | |
| VANKMEAGGIPGRVH | 441 | O60266 | |
| IVEIPHFGSMRGKER | 1061 | Q12955 | |
| HPMIDINGIIVFGTR | 196 | P20908 | |
| NGTEMKLEPGSRHQL | 76 | Q02246 | |
| PSRGLLHGNTMEKLI | 476 | Q12852 | |
| MEGIPTVELSGRKQH | 321 | O75342 | |
| LGPMIHAEVGNTVLI | 811 | Q6MZM0 | |
| EAVPHVLQILGMGSK | 1151 | Q9Y4F3 | |
| DKMSGTVHQIPQGDR | 1466 | Q9P267 | |
| VQMDHRPESVVLVKG | 391 | Q9NYP3 | |
| REQGMEVVSIEGIHP | 116 | Q14145 | |
| HVVLPGMVERKKGAI | 186 | Q3SXM5 | |
| TGEPMGRGTKVILHL | 176 | P07900 | |
| PLAAVGMDGLEKHRL | 591 | Q9UKV0 | |
| PKKHVGGRVMVTDAD | 191 | P78347 | |
| PSLKMKVVEVLAGHG | 1236 | P49327 | |
| LHGDLMAFIQPKVGL | 141 | P0C263 | |
| VGDIMLIRDHINLPG | 126 | P00491 | |
| VGRSKIVGAPMHDLL | 171 | P11586 | |
| PKIIRQEEGLHAGTM | 501 | P19022 | |
| LLHKEMLGGEIIPRS | 576 | Q16531 | |
| FTKIPHGVSGVQDRM | 341 | Q9BPU6 | |
| GDRPGLLNVGHIEKM | 386 | Q07869 | |
| REIPVAIKTLKGGHM | 656 | Q9UF33 | |
| EAHKEVFPGQRVGKM | 136 | Q13505 | |
| HMVKETVLGSDRPGV | 361 | Q8IUD6 | |
| ALHRQMKLLGEDSPV | 406 | Q9HAU8 | |
| VRFLPDGGKEVLSMH | 686 | Q9NRR4 | |
| VDLPMGGVKALTIDH | 101 | Q9H8W5 | |
| PIAKIRNIGIMAHID | 66 | Q969S9 | |
| QVLPHEREVAGALMT | 421 | Q14542 | |
| EFIMEGPLTRIGAKH | 441 | Q07890 | |
| LGIPLEMVHKGLRVG | 146 | Q9NX52 | |
| GLRPVDVGFMKALHE | 166 | Q99719 | |
| QVHRMIAEFKLIPGL | 406 | Q8TEL6 | |
| ESGGSPDVLQMLKIH | 51 | Q15628 | |
| IRAGKPVEMTGKHQL | 111 | P04053 | |
| PVEMTGKHQLVVRRD | 116 | P04053 | |
| IRMIGHNVEGPFSKA | 106 | Q969F9 | |
| MHPRVGETLKNLAVL | 1256 | Q7Z494 | |
| LVGVPLEMVHGATRI | 236 | P58872 | |
| PSERQDNHGMLLKGE | 476 | Q8TC59 | |
| VGHLSSKPERDVLMQ | 91 | O60331 | |
| LRGIGQVLPTHLMEE | 796 | Q05397 | |
| AIHLEGQKGMGLTPE | 166 | Q5VWT5 | |
| KEQTVPIRSHLMELG | 1411 | Q96Q15 | |
| GRIVPSEKILMQDHI | 446 | Q7Z3Z4 | |
| NRLKVMPFAGVLEHI | 191 | Q9H156 | |
| QELLSDMGDPKVVHG | 71 | Q86T20 | |
| HLDLEPMEKRQLIGT | 436 | Q9Y2E8 | |
| MLSDAAPGKLRIVHG | 96 | Q8WVM0 | |
| IMQVIHPDGTKCLLG | 326 | Q9BQG2 | |
| MGNGVKEGPVRLHED | 1 | Q86VD7 | |
| PGFEIIHGLLDRIMQ | 506 | Q9NSD9 | |
| VLATDLMVDVPGHGK | 166 | Q96EM0 | |
| LPIDMLQGIIGAKHS | 271 | P27105 | |
| LHMEIVGTQGKPAIA | 316 | P36897 | |
| NGLLGMVKPSVHIRT | 991 | O94911 | |
| PGTRLLKMAQGHRVE | 526 | Q15003 | |
| VILMLEVGEGSHRAP | 306 | P42695 | |
| MNHITDGPRKDLVKG | 511 | Q63HN8 | |
| QHLMKGGDLPSVEEV | 541 | Q9H4B4 | |
| IVLEAGIGHRTVPML | 1731 | Q96RL7 | |
| RVGMEVAPHLKETLN | 341 | Q7Z3J2 | |
| VMRGIFIKHVLEDSP | 1181 | O75970 | |
| RIPDQLVILDMKHGV | 116 | P49755 | |
| KKQGEGVPDLVHVMR | 321 | P35813 | |
| PEMHLIQTGKGEAIR | 2301 | Q15413 | |
| MEPGITTELVHFIKG | 4256 | Q15413 | |
| ERMDLPQGLRGKHHV | 836 | Q96PX9 | |
| EGVPMRKGEHLGEFN | 361 | Q9UG56 | |
| VKHGVMDIGLDSQDP | 596 | Q8N1W2 | |
| KTGIEHGAMPEQIVV | 721 | Q8WVM7 | |
| KHLGVPNGRMVLAVS | 6 | O43566 | |
| MSIGVPIKVLHEAEG | 1 | P62318 | |
| MEEGNKFLGHRIIPI | 756 | Q00722 | |
| RMHDELLQAVSKGPV | 21 | Q3KNS6 | |
| MILRKGSFGLHAQPE | 901 | Q9BZ71 | |
| PTANMGILVGKHVDA | 91 | Q8IX04 | |
| GPSEMQEVHLKIGIG | 126 | Q08ER8 | |
| QSLGRPEVHMALDVV | 3861 | Q7Z7G8 | |
| PQVRGMHTIIRDKET | 331 | Q9NWZ5 | |
| IREMHIIPQKAIVGE | 66 | Q96JF6 | |
| GSPQGIVGMLKRHEL | 516 | Q8NEE8 | |
| LVHEGKQVMADSGPI | 1126 | P35442 | |
| MGPKGVSVDRNGHII | 576 | Q9C040 | |
| HKLLPEIAQMFVRVG | 856 | Q9P2L0 | |
| VGEKLEHMGNTPLKI | 211 | Q9Y462 | |
| HLERQMGGQLLEEPK | 716 | O95185 | |
| GVTQEVIRHKEVMPR | 1331 | Q6ZQQ6 | |
| EVEMLKGLQHPNIVR | 221 | Q96J92 | |
| AEEHNIVFMPVIGKR | 781 | Q9UBB9 | |
| ELPKLVISVHGGMQK | 131 | Q96QT4 | |
| MGHGISLIRNGDKLP | 166 | Q6ZT98 | |
| TGNGKHVPRAVMIDL | 56 | Q9NY65 | |
| GTHGRIKFMVDIPII | 91 | Q9H354 | |
| MGPKGVAVDRNGHII | 576 | O75382 | |
| RHIGPGDKDQREMLQ | 66 | P23378 | |
| PMIIHLLDKGDFGTQ | 371 | O00629 | |
| MGRPILGEHTKLEVI | 701 | P32418 | |
| DLLSKMVVGQPHFVR | 936 | Q8NEV4 | |
| DLLSKMVVGQPHFVR | 941 | Q8WXR4 | |
| RPDEALVVHGNVKVM | 566 | Q9Y2G1 |